Neuroimmune interactions: Potential target for mitigating or treating intestinal radiation injury

British Journal of Radiology

Volumn 80, Issue SPEC. ISS. 1, 2007, Pages

  Wang, J ^a   Hauer Jensen, Martin ^a,b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; HISTAMINE; NEUROKININ; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE; SUBSTANCE P;

APOPTOSIS; CELL FUNCTION; CELL PROLIFERATION; CONFERENCE PAPER; HISTAMINE RELEASE; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INTESTINE BLOOD FLOW; INTESTINE CELL; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE MUCOSA; INTESTINE RADIATION INJURY; MAST CELL; MUCOSA INFLAMMATION; NONHUMAN; RADIATION INJURY; RADIATION RESPONSE; SENSORY NERVE; SENSORY NERVE CELL; TISSUE INJURY;

ANIMALS; ENTERIC NERVOUS SYSTEM; HUMANS; INTESTINAL MUCOSA; MAST CELLS; RADIATION INJURIES; SIGNAL TRANSDUCTION;

EID: 34948877458     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/33057885     Document Type: Conference Paper

References (83)

1. Denham JW, Hauer-Jensen M, Peters LJ. Is it time for a new formalism to categorise normal tissue radiation injury? Int J Radiat Oncol Biol Phys 2001;50:1105-6.
2. Denham JW, Hauer-Jensen M. The radiotherapeutic injury - a complex "wound". Radiother Oncol 2002;63:129-45.
3. Fajardo LF. Alimentary tract. In: Fajardo LF, editor. Pathology of radiation injury. New York, NY: Masson Publishing, 1982:47-76.
4. Fajardo LF, Berthrong M, Anderson RE. Alimentary tract. In: Fajardo LF, Berthrong M, Anderson RE, editors. Radiation pathology. New York, NY: Oxford University Press, 2001:209-47.
5. Carr KE. Effects of radiation damage on intestinal morphology. Int Rev Cytol 2001;208:1-119.
6. Hauer-Jensen M, Wang J, Denham JW. Mechanisms and modification of the radiation response of gastrointestinal organs. In: Milas L, Ang KK, Nieder C, editors. Modification of radiation response: cytokines, growth factors, and other biological targets. Heidelberg, Germany: Springer Verlag, 2002:49-72.
7. Wang J, Zheng H, Kulkarni A, Ou X, Hauer-Jensen M. Regulation of early and delayed radiation responses in rat small intestine by capsaicin-sensitive nerves. Int J Radiat Oncol Biol Phys 2006;64:1528-36.
8. Wang J, Qiu X, Kulkarni A, Hauer-Jensen M. Calcitonin gene-related peptide and substance P regulate the intestinal radiation response. Clin Cancer Res 2006;12:4112-18.
9. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996;334:1106-15.
10. Grundy D, Schemann M. Enteric nervous system. Curr Opin Gastroenterol 2006;22:102-10.
11. Grundy D, Al-Chaer ED, Aziz Q, Collins SM, Ke M, Tache Y, et al. Fundamentals of neurogastroenterology: basic science. Gastroenterology 2006;130:1391-411.
12. Fukuzumi T, Waki N, Kanakura Y, Nagoshi J, Hirota S, Yoshikawa K, et al. Differences in irradiation susceptibility and turnover between mucosal and connective tissue-type mast cells of mice. Exp Hematol 1990;18:843-7.
13. Sedgwick DM, Ferguson A. Dose-response studies of depletion and repopulation of rat intestinal mucosal mast cells after irradiation. Int J Radiat Biol 1994;65:483-95.
14. Stein J, Ries J, Barrett KE. Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells. Am J Physiol 1998;274:G203-9.
15. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-7.
16. Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994;266:G222-9.
17. Komatsu S, Grisham MB, Russell JM, Granger DN. Enhanced mucosal permeability and nitric oxide synthase activity in jejunum of mast cell deficient mice. Gut 1997;41:636-41.
18. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996;381:77-80.
19. Zheng H, Wang J, Hauer-Jensen M. Role of mast cells in early and delayed radiation injury in rat intestine. Radiat Res 2000;153:533-9.
20. Horiguchi K, Komuro T. Ultrastructural characterization of interstitial cells of Cajal in the rat small intestine using control and Ws/Ws mutant rats. Cell Tissue Res 1998;293:277-84.
21. Tsujimura T, Hirota S, Nomura S, Niwa Y, Yamazaki M, Tono T, et al. Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene. Blood 1991;78:1942-6.
22. Niwa Y, Kasugai T, Ohno K, Morimoto M, Yamazaki M, Dohmae K, et al. Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. Blood 1991;78:1936-41.
23. Galli SJ, Gordon JR, Wershil BK. Cytokine production by mast cells and basophils. Curr Opin Immunol 1991;3: 865-73.
24. Dackiw APB, Nathens AB, Ribeiro MB, Cheung PYC, Marshall JC, Rotstein OD. Mast cell modulation of macrophage procoagulant activity and TNF production. J Surg Res 1995;59:1-5.
25. Malaviya R, Abraham SN. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leuk Biol 2000;67:841-6.
26. Coleman JW, Holliday MR, Kimber I, Zsebo KM, Galli SJ. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol 1993;150:556-62.
27. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004;432:512-16.
28. Leon A, Buriani A, Dal Taso R, Fabris M, Romanello S, Aloe L, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994;92:3739-43.
29. Walls AF, Bennett AR, Godfrey RC, Holgate ST, Church MK. Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease. Clin Sci 1991;81:183-8.
30. Travis EL, Harley RA, Fenn JO, Klobukowski CJ, Hargrove HB. Pathologic changes in the rat lung following single and multiple fraction irradiation. Int J Radiat Oncol 1977;2:475-90.
31. Watanabe S, Watanabe K, Ohishi T, Aiba M, Kageyama K. Mast cells in the rat alveolar septa undergoing fibrosis after ionizing irradiation. Lab Invest 1974;31:555-67.
32. Ward WF, Molteni A, Ts'ao C, Hinz JM. Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 1990;19:1405-9.
33. Graham MM, Evans ML, Dahlen DD, Mahler PA, Rasey JS. Pharmacologic alteration of the lung vascular response to radiation. Int J Radiat Oncol Biol Phys 1990;19:329-39.
34. Norrby K, Abok K, Adamson P, Forsberg B. Radiation effects on mast cells: secretory ability, histamine release and recovery, and cell number. Acta Pathol Microbiol Scand A 1984;92:417-27.
35. Richter KK, Langberg CW, Sung C-C, Hauer-Jensen M. Increased transforming growth factor b (TGF-b) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. Int J Radiat Oncol Biol Phys 1997;39:187-95.
36. Leal-Berumen I, Conlon P, Marshall JS. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol 1994;152:5468-76.
37. Gruber BL, Marchese MJ, Kew RR. Transforming growth factor-betal mediates mast cell chemotaxis. J Immunol 1994;152:5860-7.
38. Wang J, Zheng H, Hollenberg MD, Vijesuriya SJ, Ou X, Hauer-Jensen M. Upregulation and activation of proteinase-activated receptor-2 (PAR-2) in early and delayed radiation injury in the rat intestine: influence of biological PAR-2 activators. Radiat Res 2003;160:524-35.
39. Wang J, Hauer-Jensen M. Radiation toxicity and proteinase activated receptors. Drug Dev Res 2003;60:1-8.
40. MacFarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001;53: 245-82.
41. Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 2001;22:146-52.
42. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 1994;91:9200-2.
43. Mirza H, Schmidt VA, Derian CK, Jesty J, Bahou WF. Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell a- or b-tryptases. Blood 1997;90:3914-22.
44. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997;272: 4043-9.
45. Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, et al. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 1996;314:1009-16.
46. d'Andrea MR, Derian CK, Leturcq D, Baker SM, Brunmark A, Ling P, et al. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 1998;46:157-64.
47. Corvera CU, Dery O, McConalogue K, Gamp P, Thoma M, Al-Ani B, et al. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J Physiol 1999;517:741-56.
48. Green BT, Bunnett NW, Kulkarni-Narla A, Steinhoff M, Brown DR. Intestinal type 2 proteinase-activated receptors: expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport. J Pharmacol Exp Ther 2001;295:410-16.
49. Furness JB, Costa M. The enteric nervous system. New York, NY: Churchill Livingstone, 1987.
50. Skofitsch G, Savitt JM, Jacobowitz DM. Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery. Histochemistry 1985;82:5-8.
51. Stead RH. Innervation of mucosal immune cells in the gastrointestinal tract. Reg Immunol 1992;4:91-9.
52. Bienenstock J, MacQueen G, Sestini P, Marshall JS, Stead RH, Perdue MH. Mast cell/nerve interactions in vitro and in vivo. Am Rev Respir Dis 1991;143:S55-8.
53. Vergara P, Saavedra Y, Juanola C. Neuroendocrine control of intestinal mucosal mast cells under physiological conditions. Neurogastroenterol Motil 2002;14:35-42.
54. Sharkey KA. Substance P and calcitonin gene-related peptide (CGRP) in gastrointestinal inflammation. Ann NY Acad Sci 1992;664:425-42.
55. Wang L, Stanisz AM, Wershil BK, Galli SJ, Perdue MH. Substance P induces ion secretion in mouse small intestine through effects on enteric nerves and mast cells. Am J Physiol 1995;269:G85-92.
56. Kraneveld AD, Muis T, Koster AS, Nijkamp FP. Role of mucosal mast cells in early vascular permeability changes of intestinal DTH reaction in the rat. Am J Physiol 1998;274:G832-9.
57. Frieling T, Cooke HJ, Wood JD. Neuroimmune communication in the submucous plexus of guinea pig colon after sensitization to milk antigen. Am J Physiol 1994;267:G1087-93.
58. Nilsson G, Forsberg-Nilsson K, Xiang Z, Hallbook F, Nilsson K, Metcalfe DD. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997;27:2295-301.
59. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991;43:143-201.
60. Holzer P. Capsaicin as a tool for studying sensory neuron functions. Adv Exp Med Biol 1991;298:3-16.
61. Caterina MJ, Schumacher MA, Tominga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389:816-24.
62. Evangelista S, Meli A. Influence of capsaicin-sensitive fibres on experimentally-induced colitis in rats. J Pharm Pharmacol 1989;41:574-5.
63. Barada KA, Kafrouni MI, Khoury CI, Saade NE, Mourad FH, Szabo SS, et al. Experimental colitis decreases rat jejunal amino acid absorption: role of capsaicin sensitive primary afferents. Life Sci 2001;69:3121-31.
64. Domek MJ, Blackman EI, Kao J, Zhang XY, Iwata F, Seno K, et al. Functional ablation of afferent nerves aggravates dextran sulphate sodium-induced colonic damage in rats. J Gastroenterol Hepatol 1997;12:698-702.
65. Gottwald T, Lhotak S, Stead RH. Effect of truncal vagotomy and capsaicin on mast cells and IgA-positive plasma cells in rat jejunal mucosa. Neurogastroenterol Motil 1997;9:25-32.
66. Picard C, Wysocki J, Linard C, Garcia-Villar R, Bueno L, Griffiths NM, et al. Absence of protective role of afferent nerves in early intestinal mucosal alterations induced by abdominal irradiation in rats. Int J Radiat Biol 2001;77:349-56.
67. Cocchiara R, Lampiasi N, Albeggiani G, Bongiovanni A, Azzolina A, Geraci D. Mast cell production of TNF-a induced by substance P: evidence for a modulatory role of substance P-antagonists. J Neuroimmunol 1999;101:128-36.
68. Matsuda H, Kawakita K, Kiso Y, Nakano T, Kitamura Y. Substance P induces granulocyte infiltration through degranulation of mast cells. J Immunol 1989;142:927-31.
69. Karmeli F, Eliakim R, Okon E, Rachmilewitz D. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Gastroenterology 1991;100:1206-16.
70. Rydning A, Lyng O, Aase S, Gronbech JE. Substance P may attenuate gastric hyperemia by a mast cell-dependent mechanism in the damaged gastric mucosa. Am J Physiol 1999;277:G1064-73.
71. Di Sebastiano P, Grossi L, Di Mola FF, Angelucci D, Friess H, Marzio L, et al. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig Dis Sci 1999;44:439-44.
72. Katayama I, Nishioka K. Substance P augments fibrogenic cytokine-induced fibroblast proliferation: possible involvement of neuropeptide in tissue fibrosis. J Dermatol Sci 1997;15:201-6.
73. Castagliuolo I, Riegler M, Pasha A, Nikulasson S, Lu B, Gerard C, et al. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis. J Clin Invest 1998;101: 1547-50.
74. Cao T, Gerard NP, Brain SD. Use of NK1 knockout mice to analyze substance P-induced edema formation. Am J Physiol 1999;277:R476-81.
75. Sturiale S, Barbara G, Qiu B, Figini M, Geppetti P, Gerard N, et al. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA 1999;96:11653-8.
76. Christensen HD, Haley TJ. Distribution of substance P in the central nervous system and small intestine of the rat after X-irradiation. Radiat Res 1968;33:588-95.
77. Esposito V, Linard C, Maubert C, Aigueperse J, Gourmelon P. Modulation of gut substance P after whole-body irradiation. A new pathological feature. Dig Dis Sci 1996;41:2070-7.
78. Hockerfeit U, Franzen L, Kjorell U, Forsgren S. Parallel increase in substance P and VIP in rat duodenum in response to irradiation. Peptides 2000;21:271-81.
79. Forsgren S, Hockerfelt U, Norrgard O, Henriksson R, Franzen L. Pronounced substance P innervation in irradiation-induced enteropathy - a study on human colon. Regul Pept 2000;88:1-13.
80. Esposito V, Linard C, Wysocki J, Griffiths NM, Mathe D. A substance P receptor antagonist (FK 888) modifies gut alterations induced by ionizing radiation. Int J Radiat Biol 1998;74:625-32.
81. Alfieri AB, Gardner CJ. Effects of GR203040, an NK1 antagonist, on radiation- and cisplatin-induced tissue damage in the ferret. Gen Pharmacol 1998;31:741-6.
82. Crowe R, Vale J, Trott KR, Soediono P, Robson T, Burnstock G. Radiation-induced changes in neuropeptides in the rat urinary bladder. J Urol 1996;156:2062-6.
83. Reinshagen M, Flaming G, Ernst S, Geerling I, Wong H, Walsh JH, et al. Calcitonin gene-related peptide mediates the protective effect of sensory nerves in a model of colonic injury. J Pharmacol Exp Ther 1998;286:657-61.